Dr. Prafulla Shembalkar
Claim this profileGetwell Hospital & Research Institute
Studies Migraine Headaches
Studies Migraine
4 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Prafulla Shembalkar is currently running
Lasmiditan
for Pediatric Migraine
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
Recruiting2 awards Phase 3
Galcanezumab
for Migraine
The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Recruiting1 award Phase 31 criteria
More about Prafulla Shembalkar
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Prafulla Shembalkar has experience with
- Galcanezumab
- Placebo
- Lasmiditan
Breakdown of trials Prafulla Shembalkar has run
Migraine Headaches
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Prafulla Shembalkar specialize in?
Prafulla Shembalkar focuses on Migraine Headaches and Migraine. In particular, much of their work with Migraine Headaches has involved treating patients, or patients who are undergoing treatment.
Is Prafulla Shembalkar currently recruiting for clinical trials?
Yes, Prafulla Shembalkar is currently recruiting for 4 clinical trials in Nagpur Maharashtra. If you're interested in participating, you should apply.
Are there any treatments that Prafulla Shembalkar has studied deeply?
Yes, Prafulla Shembalkar has studied treatments such as Galcanezumab, Placebo, Lasmiditan.
What is the best way to schedule an appointment with Prafulla Shembalkar?
Apply for one of the trials that Prafulla Shembalkar is conducting.
What is the office address of Prafulla Shembalkar?
The office of Prafulla Shembalkar is located at: Getwell Hospital & Research Institute, Nagpur, Maharashtra 440012 India. This is the address for their practice at the Getwell Hospital & Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.